{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:02:30Z","timestamp":1783630950193,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["RGNS 63 - 049"],"award-info":[{"award-number":["RGNS 63 - 049"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The rate of cholangiocarcinoma (CCA) is increasing every year, especially in northeastern Thailand. Screening for CCA using ultrasonography (US) is the fastest technique to identify patients in early stage of CCA development. Currently, few studies have examined patterns of hepatobiliary abnormalities identified using US, which can be indicative of CCA. We aim to evaluate the rate of CCA and its relations to history of US findings. Our study included participants who underwent US and pathological diagnosis of CCA from the Cholangiocarcinoma Screening and Care Program, Northeast Thailand between 2013 and 2020. Data on histological findings were based on the standard protocol of the tertiary hospital at Khon Kaen University. CCA data is categorized into two groups (yes\/no) to find the relationship with history of US findings. The adjusted odds ratio (AOR) and their 95% confidence intervals (CI) were used to evaluate the relationship obtained by multiple logistic regression. Of 1880 subjects who underwent US and a pathological diagnosis of CCA, the overall rate of CCA was 35.74%. CCA rate among those with liver mass (LM) was 54.85% and with dilated bile duct (DBD) was 62.01%. The relationship between DBD and CCA was highly significant (AOR\u2009=\u20093.46; 95% CI 2.74\u20134.36) followed by LM (AOR\u2009=\u20092.28; 95% CI 1.81\u20132.86) <jats:italic>P<\/jats:italic> value\u2009&lt;\u20090.001. Our study reveals that US findings history have a strong association with CCA, especially in people diagnosed with DBD and LM. Therefore, these abnormalities can be indicators for suspected CCA diagnosis through US.<\/jats:p>","DOI":"10.1038\/s41598-022-17794-9","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T10:02:35Z","timestamp":1659780155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Associations between ultrasound screening findings and cholangiocarcinoma diagnosis in an at-risk population"],"prefix":"10.1038","volume":"12","author":[{"given":"Kavin","family":"Thinkhamrop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narong","family":"Khuntikeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nittaya","family":"Chamadol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apiporn T.","family":"Suwannatrai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surachai","family":"Phimha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,6]]},"reference":[{"key":"17794_CR1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000453013","volume":"32","author":"MM Kirstein","year":"2016","unstructured":"Kirstein, M. M. & Vogel, A. Epidemiology and risk factors of cholangiocarcinoma. Visc. Med. 32, 395\u2013400 (2016).","journal-title":"Visc. Med."},{"key":"17794_CR2","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.cgh.2007.05.020","volume":"5","author":"TM Welzel","year":"2007","unstructured":"Welzel, T. M. et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based case\u2013control study. Clin. Gastroenterol. Hepatol. 5, 1221\u20131228 (2007).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"17794_CR3","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1053\/j.gastro.2004.12.048","volume":"128","author":"YH Shaib","year":"2005","unstructured":"Shaib, Y. H., El-Serag, H. B., Davila, J. A., Morgan, R. & McGlynn, K. A. Risk factors of intrahepatic cholangiocarcinoma in the United States: A case\u2013control study. Gastroenterology 128, 620\u2013626 (2005).","journal-title":"Gastroenterology"},{"key":"17794_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1478-3231.2009.02149.x","volume":"30","author":"LY Tao","year":"2010","unstructured":"Tao, L. Y. et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A case\u2013control study in China. Liver Int. 30, 215\u2013221 (2010).","journal-title":"Liver Int."},{"key":"17794_CR5","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/j.1572-0241.2007.01104.x","volume":"102","author":"YH Shaib","year":"2007","unstructured":"Shaib, Y. H. et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A hospital-based case\u2013control study. Am. J. Gastroenterol. 102, 1016\u20131021 (2007).","journal-title":"Am. J. Gastroenterol."},{"key":"17794_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","volume":"72","author":"O Clements","year":"2020","unstructured":"Clements, O., Eliahoo, J., Kim, J. U., Taylor-Robinson, S. D. & Khan, S. A. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis. J. Hepatol. 72, 95\u2013103 (2020).","journal-title":"J. Hepatol."},{"key":"17794_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.5604\/01.3001.0010.0293","volume":"16","author":"P Chinchilla-Lopez","year":"2017","unstructured":"Chinchilla-Lopez, P. et al. Prevalence, risk factors, and survival of patients with intrahepatic cholangiocarcinoma. Ann. Hepatol. 16, 565\u2013568 (2017).","journal-title":"Ann. Hepatol."},{"key":"17794_CR8","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/ueg2.12154","volume":"9","author":"N Barner-Rasmussen","year":"2021","unstructured":"Barner-Rasmussen, N., Pukkala, E., Hadkhale, K. & Farkkila, M. Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland. United Eur. Gastroenterol. J. 9, 1128\u20131135 (2021).","journal-title":"United Eur. Gastroenterol. J."},{"key":"17794_CR9","doi-asserted-by":"publisher","first-page":"16855","DOI":"10.1038\/s41598-020-73771-0","volume":"10","author":"K Thinkhamrop","year":"2020","unstructured":"Thinkhamrop, K. et al. Spatial analysis of hepatobiliary abnormalities in a population at high-risk of cholangiocarcinoma in Thailand. Sci. Rep. 10, 16855 (2020).","journal-title":"Sci. Rep."},{"key":"17794_CR10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/jhbp.64","volume":"21","author":"N Chamadol","year":"2014","unstructured":"Chamadol, N. et al. Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients. J. Hepat. Pancreat. Sci. 21, 316\u2013322 (2014).","journal-title":"J. Hepat. Pancreat. Sci."},{"key":"17794_CR11","first-page":"415","volume":"97","author":"P Apisarnthanarak","year":"2014","unstructured":"Apisarnthanarak, P., Pansri, C., Maungsomboon, K. & Thamtorawat, S. The CT appearances for differentiating of peripheral, mass-forming cholangiocarcinoma and liver meatastases from colorectal adenocarcinoma. J. Med. Assoc. Thai. 97, 415\u2013422 (2014).","journal-title":"J. Med. Assoc. Thai."},{"key":"17794_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","volume":"13","author":"JM Banales","year":"2016","unstructured":"Banales, J. M. et al. Expert consensus document: Cholangiocarcinoma\u2014current knowledge and future perspectives consensus statement from the European network for the study of cholangiocarcinoma (ENS-CCA). Nat. Rev. Gastroenterol. Hepatol. 13, 261\u2013280 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"17794_CR13","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1002\/cncr.32803","volume":"126","author":"AA Florio","year":"2020","unstructured":"Florio, A. A. et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer 126, 2666\u20132678 (2020).","journal-title":"Cancer"},{"key":"17794_CR14","doi-asserted-by":"publisher","first-page":"7160","DOI":"10.3748\/wjg.v23.i39.7160","volume":"23","author":"R Chaiteerakij","year":"2017","unstructured":"Chaiteerakij, R. et al. Characteristics and outcomes of cholangiocarcinoma by region in Thailand: A nationwide study. World J. Gastroenterol. 23, 7160\u20137167 (2017).","journal-title":"World J. Gastroenterol."},{"key":"17794_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/MOG.0b013e3282fbf9b3","volume":"24","author":"B Sripa","year":"2008","unstructured":"Sripa, B. & Pairojkul, C. Cholangiocarcinoma: Lessons from Thailand. Curr. Opin. Gastroenterol. 24, 349\u2013356 (2008).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"17794_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12885-015-1475-7","volume":"15","author":"N Khuntikeo","year":"2015","unstructured":"Khuntikeo, N. et al. Cohort profile: Cholangiocarcinoma screening and care program (CASCAP). BMC Cancer 15, 459 (2015).","journal-title":"BMC Cancer"},{"key":"17794_CR17","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.hpb.2019.10.010","volume":"22","author":"N Khuntikeo","year":"2020","unstructured":"Khuntikeo, N. et al. A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients. HPB (Oxford) 22, 874\u2013883 (2020).","journal-title":"HPB (Oxford)"},{"key":"17794_CR18","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1136\/gutjnl-2011-301748","volume":"61","author":"SA Khan","year":"2012","unstructured":"Khan, S. A. et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: An update. Gut 61, 1657\u20131669 (2012).","journal-title":"Gut"},{"key":"17794_CR19","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1148\/radiology.172.3.2549565","volume":"172","author":"BI Choi","year":"1989","unstructured":"Choi, B. I. et al. Hilar cholangiocarcinoma: Comparative study with sonography and CT. Radiology 172, 689\u2013692 (1989).","journal-title":"Radiology"},{"key":"17794_CR20","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12885-016-2390-2","volume":"16","author":"P Sungkasubun","year":"2016","unstructured":"Sungkasubun, P. et al. Ultrasound screening for cholangiocarcinoma could detect premalignant lesions and early-stage diseases with survival benefits: A population-based prospective study of 4225 subjects in an endemic area. BMC Cancer 16, 346 (2016).","journal-title":"BMC Cancer"},{"key":"17794_CR21","doi-asserted-by":"publisher","first-page":"e0009741","DOI":"10.1371\/journal.pntd.0009741","volume":"15","author":"K Thinkhamrop","year":"2021","unstructured":"Thinkhamrop, K. et al. Association of comorbidity between Opisthorchis viverrini infection and diabetes mellitus in the development of cholangiocarcinoma among a high-risk population, northeastern Thailand. PLoS Negl. Trop. Dis. 15, e0009741 (2021).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"17794_CR22","first-page":"605","volume":"19","author":"S Kamsa-ard","year":"2018","unstructured":"Kamsa-ard, S. et al. Risk factors for cholangiocarcinoma in Thailand: A systematic review and meta-analysis. Asian Pac. J. Cancer Prev. 19, 605\u2013614 (2018).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"17794_CR23","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/liv.12618","volume":"35","author":"BS Lee","year":"2015","unstructured":"Lee, B. S., Cha, B. H., Park, E. C. & Roh, J. Risk factors for perihilar cholangiocarcinoma: A hospital-based case\u2013control study. Liver Int. 35, 1048\u20131053 (2015).","journal-title":"Liver Int."},{"key":"17794_CR24","doi-asserted-by":"publisher","first-page":"14263","DOI":"10.1038\/s41598-019-50476-7","volume":"9","author":"AT Suwannatrai","year":"2019","unstructured":"Suwannatrai, A. T. et al. Bayesian spatial analysis of cholangiocarcinoma in Northeast Thailand. Sci. Rep. 9, 14263 (2019).","journal-title":"Sci. Rep."},{"key":"17794_CR25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1245\/s10434-017-6025-x","volume":"25","author":"YS Chun","year":"2018","unstructured":"Chun, Y. S., Pawlik, T. M. & Vauthey, J. N. 8th edition of the AJCC cancer staging manual: Pancreas and hepatobiliary cancers. Ann. Surg. Oncol. 25, 845\u2013847 (2018).","journal-title":"Ann. Surg. Oncol."},{"key":"17794_CR26","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge, S. B. & Compton, C. C. The American joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 17, 1471\u20131474 (2010).","journal-title":"Ann. Surg. Oncol."},{"key":"17794_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/MEG.0000000000002313","volume":"34","author":"F Baidoun","year":"2022","unstructured":"Baidoun, F., Sarmini, M. T., Merjaneh, Z. & Moustafa, M. A. Controversial risk factors for cholangiocarcinoma. Eur. J. Gastroenterol. Hepatol. 34, 338\u2013344 (2022).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"17794_CR28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3348\/kjr.2011.12.3.269","volume":"12","author":"JH Lim","year":"2011","unstructured":"Lim, J. H. Liver flukes: The malady neglected. Korean J. Radiol. 12, 269\u2013279 (2011).","journal-title":"Korean J. Radiol."},{"key":"17794_CR29","first-page":"693","volume":"34","author":"MM Fariduddin","year":"2021","unstructured":"Fariduddin, M. M., Syed, W., Birjees, A. & Naqvi, M. R. Liver infarct masquerading as intrahepatic cholangiocarcinoma. Proc. (Bayl. Univ. Med. Cent.) 34, 693\u2013695 (2021).","journal-title":"Proc. (Bayl. Univ. Med. Cent.)"},{"key":"17794_CR30","doi-asserted-by":"publisher","first-page":"e023217","DOI":"10.1136\/bmjopen-2018-023217","volume":"9","author":"N Chamadol","year":"2019","unstructured":"Chamadol, N. et al. Association between periductal fibrosis and bile duct dilatation among a population at high risk of cholangiocarcinoma: A cross-sectional study of cholangiocarcinoma screening in Northeast Thailand. BMJ Open 9, e023217 (2019).","journal-title":"BMJ Open"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17794-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17794-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17794-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:38:49Z","timestamp":1669354729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17794-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["17794"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-17794-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,6]]},"assertion":[{"value":"5 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13513"}}